Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
161 Leser
Artikel bewerten:
(1)

Accuhealth Elevates Remote Care With Introduction of Service-Level Agreements for Enhanced Patient Response

Accuhealth's Commitment to Excellence: New SLAs to Set Higher Standards for Patient Care and Outcomes

MCALLEN, TX / ACCESSWIRE / March 11, 2024 / Accuhealth is proud to announce the introduction of service-level agreements (SLAs) for patient response times, marking a significant advancement in the quality of remote patient monitoring (RPM) services. These SLAs embody Accuhealth's dedication to setting higher benchmarks in patient care, ensuring that every patient receives timely and effective responses, thereby enhancing their overall health outcomes and experiences with RPM.

Accuhealth

Accuhealth Remote Patient Monitoring and Chronic Care Management RPM CCM

"Accuhealth is setting new industry standards in the field of RPM by proactively launching SLAs and further enhancing Accuhealth's RPM," said Stephen Samson, CEO of Accuhealth. "Our clients' need for SLAs for different levels of monitoring is a testament to the overall effectiveness of RPM. It underscores the diversity of monitoring services required to cater to various patient groups, each with distinct health requirements."

Accuhealth's commitment to swift response times is reflected in its standard service. Understanding that each client may have unique needs and requirements, Accuhealth offers its clients the option to tailor their own response times based on patient necessities. This adaptability enables Accuhealth to optimally serve a diverse range of patient groups, cater to their specific health needs, and align its services with the objectives of each value-based care organization Accuhealth collaborates with.

Value-based care organizations, which are dedicated to enhancing patient outcomes while minimizing costs, increasingly appreciate the necessity for rapid and efficient patient monitoring. Accuhealth's newly introduced SLAs are attracting interest from these organizations, whose objectives of enhancing patient experiences and reducing unnecessary hospital visits align with Accuhealth's new initiative.

For more information about Accuhealth's SLAs and the benefits of Accuhealth's RPM system, contact info@accuhealth.tech.

About Accuhealth
Accuhealth empowers physicians with the right data to stay ahead of negative health outcomes to keep patients healthy, happy, and out of the hospital. Founded in 2018, Accuhealth is a leading healthcare technology provider of turn-key remote patient monitoring solutions worldwide, providing hardware, software, and first-line 24/7/365 clinical monitoring to physicians with real-time vital information and AI-enhanced data. Accuhealth's services yield improved outcomes, increased patient satisfaction, reduced costs for payors, and increased revenue for clinics. Accuhealth's touchpoints as a service makes remote monitoring a breeze for providers, their patients, and clinical staff. Accuhealth offers Chronic Care Management and Remote Patient Monitoring Made Easy and Done Right®. Visit www.accuhealth.tech for more information.

# # #

Press contact:

Inga Vitols
Accuhealth
ivitols@accuhealth.tech

Contact Information:

Inga Vitols
PR Coordinator, Accuhealth
ivitols@accuhealth.tech
(213) 270-1175

SOURCE: Accuhealth

.

View the original press release on newswire.com.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.